On November 28, 2025, the SinoUnited Health International Medical Forum themed as "China lnnovation in Global Healthcare" was successfully held in Shanghai. The forum brought together renowned medical experts from China and abroad, as well as entrepreneurs and executives from sectors including technology, finance, and education, for insightful sharing and dialogues to explore new trends and innovative practices in global health development.
The forum featured three parallel sub-forums throughout the day: the CAR-T and Advances in Hematology, Women's Health, and Healthcare Innovation. Through keynote speeches and roundtable discussions covering frontier hematologic oncology treatments, full-cycle women's health guardianship, the application of AI technology in healthcare, and explorations in longevity medicine, the 2025 SinoUnited Health International Medical Forum established an international exchange platform, effectively promoting the deep integration of global cutting-edge medical expertise with clinical practice in China.
Dr. Kathy Shi, Founder and CEO of SinoUnited Health, emphasized, "‘China lnnovation in Global Healthcare' is not just a slogan, but the consistent development path of SinoUnited Health. We are committed to gathering top global medical resources to ‘bring in' the world's most advanced medical wisdom; simultaneously, we integrate international experience with local realities to explore locally innovative medical service models in practice, demonstrating China's implementation speed and model innovation."
Focus on Hematology: Decoding Frontier Advances in CAR-T Therapy
As a major center for medical science in Asia, Shanghai, leveraging its profound accumulation and pioneering exploration in the treatment of blood diseases, is increasingly becoming an important medical destination attracting global patients.
CAR-T cell therapy (Chimeric Antigen Receptor T-Cell Immunotherapy) is a personalized cell treatment. It involves collecting a patient's own immune cells—T cells—genetically modifying them in vitroto enhance their ability to specifically recognize and kill tumor cells, and then reinfusing them.
In May 2025, the SinoUnited Health International CAR-T Cell Therapy Center was officially established. The launch of the center marks China's entry into the global first tier in the field of cell therapy. In just over a year, SinoUnited Health has received inquiries from more than 100 overseas patients globally and has successfully completed CAR-T cell treatment for over 20 patients from countries including New Zealand, the United Kingdom, Germany, France, Canada, and Singapore.
Professor Justin Zhu, Co-Chief Medical Officer of SinoUnited Health, delivered the opening address and shared SinoUnited Health's dedicated philosophy and development vision in the field of hematologic oncology.
The first academic session was chaired by Prof. Hua Shen, Medical President, Shanghai SinoUnited Hospital, Co-Chief Medical Officer, SinoUnited Health. Prof. Zhao Weili from Ruijin Hospital presented a report titled "Improving the Treatment of R/R LBCL in China: Exploration and Perspective".
Subsequently, the academic sharing session was chaired by Dr. Kwong Yok Lam from Hong Kong's Queen Mary Hospital. Dr. Zhou Lili, Chief of Hematology Department and international CAR-T Cell Therapy Center at SinoUnited Health, delivered a presentation on the "SinoUnited Health CAR-T Therapy Achievements and Outlook".
The session on "Management of CAR-T Toxicities and Treatment" was chaired by Prof. Aibin Liang from Tongji Hospital. Dr. Yi Lin from Mayo Clinic gave a systematic presentation on the topic.
The following academic session was chaired by Prof. Hua Yan from Ruijin Hospital. Dr. Rajiv Pruthi from Mayo Clinic provided an in-depth analysis on the "Diagnosis and Management of Bleeding Disorders" in patients with hematologic tumors.
A special patient sharing session featured Dale De Penning from New Zealand, who shared his story of rebirth. In 2023, as Dale was preparing for retirement, he experienced abdominal pain and major bleeding, leading to an emergency room visit. A biopsy diagnosed him with Stage IV diffuse large B-cell lymphoma (DLBCL). The mass, nearly 20cm, was compressing various organs like the ureter, bones, muscles, and intestines, making his condition very critical. Dale underwent three different chemotherapy regimens, all with unsatisfactory results. After careful comparison and consultation, Dale traveled from New Zealand to Shanghai SinoUnited Hospital for CAR-T cell therapy. Now, his indicators have completely normalized; he is not only mobile but can also go sea fishing and hunting in the mountains.
The forum featured two roundtable dialogues, bringing together leading authorities in hematologic oncology from China and abroad. Prof. Jian Hou from Renji Hospital, and Prof. Zhen Cai from the First Affiliated Hospital of Zhejiang University, co-moderated a roundtable titled "CAR-T Future Prospects • Global Collaboration". Participants included Dr. Kwong Yok Lam from Hong Kong's Queen Mary Hospital, Prof. Juan Du from Renji Hospital, Dr. Yi Lin from Mayo Clinic, and Dr. Lili Zhou from SinoUnited Health.
Subsequently, a roundtable dialogue on "Challenges in the Aging Era · Road to the Cure of MM" was moderated by Prof. Jianmin Yang from Changhai Hospital and Prof. Wenbin Qian from Second Affiliated Hospital of Zhejiang University. This session featured discussions with Dr. Rajiv Pruthi from Mayo Clinic, Prof. Yao Yi from the United States, Dr. Alma Calavera from the Philippines, and Dr. Itsara Anongjanya from Thailand.
Concluding the CAR-T forum, Prof. Hua Shen, stated, "The‘SinoUnited approach' demonstrates how China's CAR-T therapy, through its professional expertise and humanistic care, provides a reliable treatment option for patients worldwide. The global insights gathered and the Chinese innovations showcased at this forum fully affirm China's role as an indispensable force in the global CAR-T cell therapy landscape."
Safeguarding Health Throughout Lives, Empowering the 'She Era'
In today's world where "the power of women" is flourishing, women's health and well-being have become essential metrics for social progress and harmony. From the uncertainties of adolescence and the challenges of childbearing years to the transition through menopause and the care needed in old age, women face unique health needs at different life stages. This necessitates a shift from traditional, fragmented health services to a consistent, systematic "full life cycle" management approach.
Dr. Kathy Shi emphasized that promoting "Her Health" not only empowers women's personal development but is also a key measure to strengthen the foundation of family health and unleash the social value of "the power of women". The SinoUnited Health Women's Health Center, drawing from management models like that of Mayo Clinic, features a "General Practice + Specialists" approach covering women's entire life cycle, aiming to become a trusted "health partner" for women.
Dr. Lily Yan, Director of the SinoUnited Health Women's Center, shared the center's development journey. "From its establishment in 2019 to the present, the SinoUnited Health Women's Health Center has provided consultations for over 250,000 female patients, offered comprehensive health management services to thousands of menopausal patients, conducts nearly ten thousand breast cancer screenings annually, and has performed breast cancer surgeries for patients in need. These solid data and outcomes are a practical reflection of the philosophy of safeguarding women's health throughout the entire life cycle."
Dr. Carol Kuhle from Mayo Clinic delivered a presentation titled "Assessing and Treating Female Sexual Dysfunction" to the attending guests. She elaborated in detail on how to standardize the assessment and differentiation of female sexual health issues, and thoroughly discussed the selection and clinical application of various comprehensive treatment options, including hormone therapy and psychological-behavioral interventions.
Dr. Sandhya Pruthi, from Mayo Clinic, focused on "Breast Cancer Survivorship: Health Promotion and Management". She provided a detailed explanation on performing precise risk stratification for recurrence in breast cancer survivors and developing health promotion plans that include regular monitoring, lifestyle interventions, and psychological support.
The Women's Health forum featured two roundtable discussions, bringing together experts from the medical field, business community, and investment sector. In the roundtable titled "From Early Screening to Longevity: Investing in Women's Full Life Cycle Health", participants explored viable pathways and resource support for managing women's health throughout their lives. They emphasized that achieving full life cycle health for women requires the integration of individual decision-making, family planning, corporate support, capital, and technology to transition from disease prevention to achieving high-quality longevity. This dialogue was moderated by Dr. Lily Yan from SinoUnited Health, with participants including Dr. Sandhya Pruthi from Mayo Clinic, Ms. Chang'an Xie from PepsiCo Greater China, Ms. Xiaofei Xia Mercer and Marsh Mercer Benefits China, Ms. Jue Lu, from Shanghai Sci-Tech Bank, and Ms. Lei Hua from Longevity Asset Management.
In the roundtable discussion themed "Health: The Invisible Canvas behind Women's Leadership", guests analyzed the explorations and practices of female leaders in effectively maintaining their physical and mental health while pursuing career ambitions. The discussion highlighted that what contemporary female leaders truly need is not isolated wellness techniques, but a systematic mindset that deeply integrates health into their personal growth and organizational development strategies. This session was moderated by Ms. Sheng Lu, from Shanghai Overseas Returned Scholars Association, AEMA, AEWA. Participants included Dr. Carol Kuhle from Mayo Clinic, Dr. Yvette Kong, Chief of Gynecology Department at SinoUnited Health, Ms. Bihua Xiong, from J.P. Morgan, Ms. Xiaorong Wang from Hilton, Ms. Xiaoying Li from Shanghai World Foreign Language Academy, and Ms. Donglei Zhou from Julia Gabriel Education.
Leading the New Era of Longevity Medicine, Building an Innovative Medical Landscape
The Healthcare Innovation Forum focused on centering on frontier topics such as longevity and artificial intelligence. It explored how health management can break through traditional medical boundaries to empower individual and family health in an era of increasing life expectancy.
The SinoUnited Health Longevity Clinic team made a collective appearance through a video titled "How to Achieve Healthy Longevity?". The clinic brings together a multi-disciplinary team to deeply analyze how to achieve synergistic development of "longevity" and "high-quality life" through medical intervention and lifestyle adjustments, based on clinical practice.
Misha Mo, Director of Internet Operations at SinoUnited Health, provided a detailed introduction to the SinoUnited Health membership system, highlighting its unique advantages in delivering high-quality, personalized healthcare services.
Dr. Sumit Bhagra from Mayo Clinic delivered a presentation on "AI Applications in Diabetes: From Promise to Practice", explaining how AI enhances the precision and efficiency of diabetes management, from future prospects to clinical implementation.
In a speech titled "Transforming Healthcare with AI and Automation", Mayo Clinic's Dr. Anjali Bhangra further explored AI's evolution from an "auxiliary tool" to a "core driver of medical transformation", sharing practical experiences from leading global medical institutions.
The Healthcare Innovation Forum featured two roundtable discussions, bringing together diverse perspectives from the investment community, medical field, academia, and industry. In the roundtable titled "The New Era of Longevity Medicine: Building a Future Model for Family Wellness", moderated by Dr. Siyu Yan, Chief Physician of New Bund Clinic at SinoUnited Health, participants including Dr. Sumit Bhagra from Mayo Clinic, Prof. Shawn Qu, Chief & Chief Expert of Endocrinology, Metabolism and Thyroid Center at SinoUnited Health, Mr. Alex Gu from Medtronic, Mr. Chao Yu from BCG, and Ms. Yin Ge from Her Growth and Han Kun Law Offices, engaged in an in-depth discussion. They explored how to integrate technology and personalized solutions to extend health management from clinical settings to daily life scenarios, establishing a new proactive health model centered on prevention.
Another roundtable, titled "AI-Powered Revolution in Healthcare – Bridging the One-Meter Gap from Hospital to Home", was moderated by Motao Sun from Qiming Venture Partners. Participants including Dr. Kathy Shi, Founder and CEO of SinoUnited Health, Dr. Anjali Bhangra from Mayo Clinic, Prof. Yu Cheng from Chinese University of Hong Kong and Shanghai Artificial Intelligence Laboratory, Mr. Chuan Gao, from United Imaging Digital Solution, and Ms. Xin Liu from AON, discussed how AI technology can bridge the gap between medical institutions and home environments, reshaping health management systems.
Looking ahead, SinoUnited Health will remain steadfast in its "patient-centered" philosophy, continuously fulfilling its commitment to high-quality healthcare through professional medical services, technology-driven approaches, and humanistic care, providing better, more efficient, and more comprehensive medical services to patients both domestically and internationally.
